ClinicalTrials.Veeva

Menu

Laparoscopic Surgery of Rectal Cancer and Ileostomy

C

Campus Bio-Medico University of Rome

Status

Completed

Conditions

Leakage, Anastomotic
Ileostomy - Stoma
Ileostomy; Complications

Treatments

Procedure: elective diverting ileostomy

Study type

Observational

Funder types

Other

Identifiers

NCT04169425
11.17 OSS Comet CBM

Details and patient eligibility

About

Elective diverting ileostomy may reduce consequences of anastomotic failure in laparoscopic TME. Aiming to evaluate the effectiveness of elective diverting ileostomy, its impact on the incidence and clinical behavior of anastomotic leakage and the complications related to its presence and take down were analyzed.

Full description

From a prospective collected database, data regarding patients who underwent to laparoscopic TME, with (Group 1) or without (Group 2) elective diverting ileostomy for rectal cancer from 2012 to 2017 at University Campus Bio-Medico di Roma, have been retrospectively analyzed.

Enrollment

150 patients

Sex

All

Ages

67 to 86 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients (aged 18 years and over)
  • patients submitted to elective Anterior Rectal Resection

Exclusion criteria

  • chronic use of immunosuppressant agents
  • urgent surgery

Trial design

150 participants in 2 patient groups

Group 1
Description:
patients who underwent to laparoscopic TME, with elective diverting ileostomy for rectal cancer
Treatment:
Procedure: elective diverting ileostomy
Group 2
Description:
patients who underwent to laparoscopic TME, without elective diverting ileostomy for rectal cancer

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems